Cell-Specific Protective Signaling Induced by the Novel AT2R-Agonist NP-6A4 on Human Endothelial and Smooth Muscle Cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cell-Specific Protective Signaling Induced by the Novel AT2R-Agonist NP-6A4 on Human Endothelial and Smooth Muscle Cells
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-08-21
DOI
10.3389/fphar.2018.00928
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aldose reductase inhibitor, fidarestat prevents doxorubicin-induced endothelial cell death and dysfunction
- (2018) Himangshu Sonowal et al. BIOCHEMICAL PHARMACOLOGY
- Identification of protein phosphatase involvement in the AT 2 receptor-induced activation of endothelial nitric oxide synthase
- (2018) A. Augusto Peluso et al. CLINICAL SCIENCE
- Role of interleukin-10 in the neuroprotective effect of the Angiotensin Type 2 Receptor agonist, compound 21, after ischemia/reperfusion injury
- (2017) Abdelrahman Y. Fouda et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dickkopf1 destabilizes atherosclerotic plaques and promotes plaque formation by inducing apoptosis of endothelial cells through activation of ER stress
- (2017) Mingxue Di et al. Cell Death & Disease
- Mitochondrial respiration and ROS emission during β-oxidation in the heart: An experimental-computational study
- (2017) Sonia Cortassa et al. PLoS Computational Biology
- Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes
- (2017) Mari C. Asensio-López et al. PLoS One
- Angiotensin II affects inflammation mechanisms via AMPK-related signalling pathways in HL-1 atrial myocytes
- (2017) Nami Kim et al. Scientific Reports
- Cardiovascular disease progression in female Zucker Diabetic Fatty rats occurs via unique mechanisms compared to males
- (2017) Kelly Lum-Naihe et al. Scientific Reports
- The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis
- (2016) Bryna S. M. Chow et al. DIABETOLOGIA
- Compound 21, a selective agonist of angiotensin AT2receptors, prevents endothelial inflammation and leukocyte adhesionin vitroandin vivo
- (2015) Amanda K Sampson et al. BRITISH JOURNAL OF PHARMACOLOGY
- Functional effects of losartan in hypertrophic cardiomyopathy—a randomised clinical trial
- (2015) Anna Axelsson et al. HEART
- A Nonpeptide Angiotensin II Type 2 Receptor Agonist Prevents Renal Inflammation in Early Diabetes
- (2015) Luis C. Matavelli et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial
- (2015) Anna Axelsson et al. Lancet Diabetes & Endocrinology
- Effect of lipopolysaccharide on angiotensin II type 1 receptor expression and function in human pulmonary microvascular endothelial cells
- (2015) HONG-PENG LI et al. Molecular Medicine Reports
- Differential Effects of β-Blockers, Angiotensin II Receptor Blockers, and a Novel AT2R Agonist NP-6A4 on Stress Response of Nutrient-Starved Cardiovascular Cells
- (2015) Abuzar Mahmood et al. PLoS One
- Activation of Central Angiotensin Type 2 Receptors by Compound 21 Improves Arterial Baroreflex Sensitivity in Rats With Heart Failure
- (2014) J. Gao et al. AMERICAN JOURNAL OF HYPERTENSION
- Endothelial Dysfunction, Obesity and Insulin Resistance
- (2014) Dolores Prieto et al. Current Vascular Pharmacology
- Effects of Cardiac Overexpression of the Angiotensin II Type 2 Receptor on Remodeling and Dysfunction in Mice Post–Myocardial Infarction
- (2014) Jiang Xu et al. HYPERTENSION
- Direct Angiotensin AT2 Receptor Stimulation Using a Novel AT2 Receptor Agonist, Compound 21, Evokes Neuroprotection in Conscious Hypertensive Rats
- (2014) Claudia A. McCarthy et al. PLoS One
- A comparison of replicative senescence and doxorubicin-induced premature senescence of vascular smooth muscle cells isolated from human aorta
- (2013) Anna Bielak-Zmijewska et al. BIOGERONTOLOGY
- Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats
- (2013) Quaisar Ali et al. KIDNEY INTERNATIONAL
- PD123319 Augments Angiotensin II-Induced Abdominal Aortic Aneurysms through an AT2 Receptor-Independent Mechanism
- (2013) Alan Daugherty et al. PLoS One
- Angiotensin II, NADPH Oxidase, and Redox Signaling in the Vasculature
- (2012) Aurelie Nguyen Dinh Cat et al. ANTIOXIDANTS & REDOX SIGNALING
- The regenerative potential of angiotensin AT2 receptor in cardiac repair
- (2012) Marion Ludwig et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Angiotensin II AT2 receptor decreases AT1 receptor expression and function via nitric oxide/cGMP/Sp1 in renal proximal tubule cells from Wistar–Kyoto rats
- (2012) Jian Yang et al. JOURNAL OF HYPERTENSION
- AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function
- (2012) Shetal H. Padia et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- RAS-Mediated Adaptive Mechanisms in Cardiovascular Tissues: Confounding Factors of RAS Blockade Therapy and Alternative Approaches
- (2012) Rukhsana Gul et al. CardioRenal Medicine
- Review: Novel roles of nuclear angiotensin receptors and signaling mechanisms
- (2011) TanYa M. Gwathmey et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Angiotensin Type 2 Receptor Agonist Compound 21 Reduces Vascular Injury and Myocardial Fibrosis in Stroke-Prone Spontaneously Hypertensive Rats
- (2011) Asia Rehman et al. HYPERTENSION
- Identification and characterization of a functional mitochondrial angiotensin system
- (2011) P. M. Abadir et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats
- (2010) S Bosnyak et al. BRITISH JOURNAL OF PHARMACOLOGY
- Role of Prolylcarboxypeptidase in Angiotensin II Type 2 Receptor–Mediated Bradykinin Release in Mouse Coronary Artery Endothelial Cells
- (2010) Liping Zhu et al. HYPERTENSION
- Identification of Noncytotoxic and IL-10-Producing CD8+AT2R+ T Cell Population in Response to Ischemic Heart Injury
- (2010) C. Curato et al. JOURNAL OF IMMUNOLOGY
- Cardiac c-kit+AT2+ Cell Population is Increased in Response to Ischemic Injury and Supports Cardiomyocyte Performance
- (2009) Wassim Altarche-Xifró et al. STEM CELLS
- Enhanced Angiotensin II Type 2 Receptor Mechanisms Mediate Decreases in Arterial Pressure Attributable to Chronic Low-Dose Angiotensin II in Female Rats
- (2008) Amanda K. Sampson et al. HYPERTENSION
- AT2 receptors: Functional relevance in cardiovascular disease
- (2008) Emma S. Jones et al. PHARMACOLOGY & THERAPEUTICS
- Angiotensin II-induced vasodilation via type 2 receptor: Role of bradykinin and nitric oxide
- (2007) Katsutoshi Yayama et al. INTERNATIONAL IMMUNOPHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started